HOW LONG DOES NAD IV THERAPY TAKE? WHY NAD+ CAN'T BE RUSHED, AND HOW IT COMPARES TO INJECTIONS AND NMN

How long does NAD IV therapy take? Plan on two to three hours for a full NAD+ infusion. The exact time depends on how your body responds, and it rarely runs past three hours. A full dose cannot be given comfortably in 30 to 45 minutes, whatever a menu board says, because the speed of the drip is what produces the side effects people associate with NAD+. Here is why the rate matters, what to expect in the chair, and how NAD+ IV therapy compares to injections and oral supplements.
By Elaine Burris, APRN, FNP-C, Wellness Nurse Practitioner, Hartwater Wellness
Medically reviewed by Scott Bradley Burris, MD, Medical Director and board-certified anesthesiologist. Reviewed October 2026.
THE SHORT ANSWER
Time: allow two to three hours. Most infusions finish in that window; very few run longer than three hours.
Why so long: NAD+ is limited by how fast your body tolerates it. Push the drip too fast and most people feel nausea, cramping, flushing, or chest pressure, which fade when the drip slows.
What shortens it: Dr. Burris has developed specific NAD+ blends that help many patients tolerate a steadier rate, which shortens the infusion and makes it more comfortable.
What the evidence shows: an IV raises blood NAD+ levels, but no completed trial has yet shown that NAD+ infusions slow aging or improve energy. Oral precursors (NMN and nicotinamide riboside) raise NAD+ too, at far lower cost, with mixed results on function.
Price at Hartwater: $499 per infusion or $1,599 for four.
HOW LONG DOES NAD IV THERAPY TAKE, AND WHY?
The honest answer to "how long does NAD IV therapy take" is: as long as your body needs. NAD+ (nicotinamide adenine dinucleotide) is a molecule every cell uses to turn food into energy. When it enters the bloodstream faster than the body can handle it, the result is a recognizable set of symptoms:
nausea or stomach cramping
flushing and warmth
a tight or heavy feeling in the chest
a faster heartbeat
restlessness or a headache
In a screened patient these symptoms are uncomfortable and short-lived. They typically fade within minutes once the rate is turned down. A 2026 review of clinic records found that 500 mg NAD+ infusions caused moderate to severe stomach symptoms and chest pressure at faster rates, which resolved when the infusion slowed or ended. Because of those symptoms, the infusions took far longer on average than an infusion of a related compound.
The most careful study of IV NAD+ in humans went slower still. Researchers gave healthy men 750 mg over six hours, about two milligrams a minute, and reported no adverse events. Blood NAD+ did not change for the first two hours, then rose about fourfold by the sixth hour.
NAD+ behaves like many medications whose side effects track the infusion rate more closely than the total dose, a pattern anesthesiologists manage every day. The fix is a patient one: start slowly, watch how you respond, and adjust. A clinic that promises a full NAD+ dose in half an hour is either giving a small dose or asking you to sit through symptoms you do not need to have.
WHAT DR. BURRIS'S NAD+ BLENDS CHANGE
At Hartwater Wellness we do not run NAD+ alone at a fixed rate. Dr. Burris has developed specific NAD+ blends, combined with supportive ingredients, that many of our patients tolerate at a steadier rate. The practical result is a shorter, more comfortable infusion for most people, often toward the lower end of the two-to-three-hour window.
This comes from our clinical experience with our own patients. It has not been tested in a published trial, and we will not claim more for it than that. What it means for you: fewer pauses, less of the chest tightness and nausea people dread, and more of your afternoon back.
WHAT TO EXPECT DURING YOUR NAD+ INFUSION
Before: arrive hydrated. Many patients add a Hydration IV before an NAD+ session, which we recommend if you tend to run dry.
Settling in: A physician, nurse practitioner, or registered nurse will place your IV, and a licensed clinician stays with you for the whole infusion. Bring a laptop, a book, or headphones; most patients work or rest.
During: you may feel warmth, mild flushing, or a fluttery stomach as the rate climbs. Tell your clinician. We slow the drip, and the feeling usually passes within minutes. You set the pace.
After: most patients go back to their day. Some feel tired the first evening; others notice clearer focus. Reactions vary, and we review yours before your next session.
WHAT NAD+ DOES, AND WHAT THE EVIDENCE SHOWS
NAD+ sits at the center of cellular energy production, and it also fuels enzymes involved in DNA repair, including the sirtuins that longevity researchers study. That biology is why NAD+ draws so much attention.
The human evidence is earlier than the marketing suggests:
Levels and age. Studies of human tissue, such as skin, show lower NAD+ in older people. A large 2026 study across seven groups of adults found blood NAD+ levels did not vary with age.
IV NAD+ and outcomes. A 2026 systematic review found no completed outcome trials of IV or injected NAD+ for aging or wellness. Small studies in specific diseases, such as one heart failure trial using a much lower dose, do not translate to wellness use.
Oral precursors. Nicotinamide mononucleotide (NMN) and nicotinamide riboside (NR) reliably raise blood NAD+ in trials. Effects on function are mixed: one NMN trial improved muscle insulin sensitivity in women with prediabetes, while an NR trial in men with obesity showed no change in insulin sensitivity. Several of these trials were funded by supplement makers.
We offer NAD+ because many patients value how they feel during a series, because it raises NAD+ reliably, and because its safety record at proper rates is good. We present it as an option with promising biology and limited outcome data, and we track how you respond.
NAD+ IV VS INJECTIONS VS NMN
Each route raises NAD+ in a different way, with different evidence, time, and cost.

Many of our patients combine routes: an IV series to start, then injections or an oral supplement between sessions to keep things steady. Injectable NAD+ is prescribed through our peptide therapy program, and our team shows you how to self-inject at your first visit.
IS NAD+ IV THERAPY SAFE?
At proper rates and in screened patients, NAD+ infusions have a good safety record in the studies available, with symptoms that resolve when the drip slows. Long-term safety data are limited. Three safeguards matter most:
Pharmacy sourcing. NAD+ is not an FDA-approved drug. The FDA allows pharmacies to compound it while it reviews the ingredient (it is on the FDA's "Category 1" list), so the pharmacy's quality controls are your protection. In 2025 the FDA classified a recall of one company's compounded NAD+ injection as Class I, its most serious category, for elevated bacterial toxins. Hartwater sources its IV formulations from accredited 503B outsourcing pharmacies that test for sterility.
Screening. Heart, kidney, and medication history are reviewed before the first infusion. Read Is IV Therapy Worth It? for who should avoid elective IVs.
A clinician in the room for the whole infusion, adjusting the rate to you.
HOW WE USE NAD+ AT HARTWATER WELLNESS
NAD+ fits within three of our nine health categories: Energy and Vitality, Cognitive Health and Focus, and Anti-Aging and Skin Health. When it is part of your plan, the typical pattern is:
Loading: four infusions over two to four weeks.
Maintenance: one infusion monthly or quarterly, with injections or an oral supplement in between if you choose.
Pairing: many patients schedule NAD+ alongside hyperbaric oxygen therapy. The pairing rests on biology, since cells need both NAD+ and oxygen to produce energy; no trial has tested the combination. We explain the chamber side in Hard Shell vs Soft Shell Hyperbaric Chamber.
WHAT NAD+ IV THERAPY COSTS
An NAD+ IV is $499 per infusion, or $1,599 for a package of four. Injectable NAD+ is $285 per month. Hartwater Wellness is a cash-pay practice; HSA and FSA accepted. New patients complete a consultation before their first infusion.
FREQUENTLY ASKED QUESTIONS
How long does an NAD+ IV take?
Plan on two to three hours. The time depends on your tolerance and rarely exceeds three hours. A full dose cannot be given comfortably in 30 to 45 minutes.
Why does NAD+ make my chest feel tight?
Chest pressure, nausea, cramping, and flushing are common when NAD+ runs faster than your body tolerates. They usually fade within minutes once the drip slows. Tell your clinician as soon as you notice them.
Is NAD+ IV better than NMN supplements?
An IV raises blood NAD+ quickly and fully, while NMN and nicotinamide riboside raise it gradually and cost far less. Neither route has strong outcome evidence for aging yet, so the choice comes down to your goals, budget, and how you respond.
How often should you get an NAD+ IV?
A common pattern is four infusions over two to four weeks, then one every month or every few months. Some patients maintain levels with injections or an oral supplement between infusions.
Can NAD+ be given in 30 minutes?
Only a small dose. A full dose given that fast causes significant discomfort for most people. If a clinic quotes 30 minutes, ask how many milligrams you will receive.
SCHEDULE A CONSULTATION
Hartwater Wellness is a physician-led practice at 7200 West University Drive, Suite 170, in McKinney, serving Frisco, Allen, Prosper, Plano, Celina, and Collin County. Schedule online or call (469) 678-8748.
SOURCES
Grant R et al. A pilot study investigating changes in the human plasma and urine NAD+ metabolome during a 6-hour intravenous infusion of NAD+. Frontiers in Aging Neuroscience 2019: https://doi.org/10.3389/fnagi.2019.00257
Reyna et al., retrospective study of intravenous NAD+ and NR infusions, Frontiers in Aging 2026: https://doi.org/10.3389/fragi.2026.1652582
Alangari et al., narrative review of NAD+ therapies, Frontiers in Aging 2026: https://doi.org/10.3389/fragi.2026.1887175
Gallagher et al., systematic review of NAD+ therapies, Ageing Research Reviews 2026: https://doi.org/10.1016/j.arr.2026.103057
Massudi H et al. Age-associated changes in oxidative stress and NAD+ metabolism in human tissue. PLoS One 2012: https://doi.org/10.1371/journal.pone.0042357
Trętowicz et al., blood NAD+ across seven cohorts, Nature Metabolism 2026: https://doi.org/10.1038/s42255-026-01537-5
Yu et al., NAD+ in ischemic heart failure, American Journal of Cardiovascular Drugs 2025: https://doi.org/10.1007/s40256-025-00764-7
Yoshino M et al. Nicotinamide mononucleotide increases muscle insulin sensitivity in prediabetic women. Science 2021: https://doi.org/10.1126/science.abe9985
Okabe K et al. Oral NMN in healthy adults, Frontiers in Nutrition 2022: https://doi.org/10.3389/fnut.2022.868640
Martens CR et al. Chronic nicotinamide riboside supplementation in healthy older adults. Nature Communications 2018: https://doi.org/10.1038/s41467-018-03421-7
Dollerup OL et al. Nicotinamide riboside in obese men, American Journal of Clinical Nutrition 2018: https://doi.org/10.1093/ajcn/nqy132
Christen et al., NR vs NMN vs nicotinamide head to head, Nature Metabolism 2026: https://doi.org/10.1038/s42255-025-01421-8
U.S. Food and Drug Administration, bulk drug substances under evaluation for 503A compounding (Category 1 list, updated May 14, 2026): https://www.fda.gov/media/94155/download
Venable LLP, "FDA Declares Nicotinamide Mononucleotide Is Lawful in Dietary Supplements" (October 2025): https://www.venable.com/insights/publications/2025/10/fda-declares-nicotinamide-mononucleotide-is
U.S. Food and Drug Administration enforcement report, GenoGenix NAD+ for Injection, recall D-0094-2026 (Class I, classified October 21, 2025): https://api.fda.gov/drug/enforcement.json?search=recalling_firm:GenoGenix+AND+classification:"Class+I"
.png)


